Playback speed
10 seconds
SABCS 2022 10-Year Results of a Phase 3 Trial of Low-Dose Tamoxifen in Non-Invasive Breast Cancer
By
SABCS 2022 Conference Coverage
FEATURING
Andrea De Censi
By
SABCS 2022 Conference Coverage
FEATURING
Andrea De Censi
1,481 views
December 15, 2022
Login to view comments.
Click here to Login